Free Trial

10 Best Small Cap Stocks to Buy Now - 7 of 10

 
 

MiMedx Group (NASDAQ:MDXG)

Consensus Rating
Buy
Rating Score
3.0
Ratings Breakdown
5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$12.00 (95.8% Upside)

About MiMedx Group

MiMedx Group logoMiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
8/1/2024Craig HallumLower Price TargetBuy ➝ Buy$14.00 ➝ $12.00
8/1/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$11.00 ➝ $11.00
7/2/2024Cantor FitzgeraldInitiated CoverageOverweight$11.00
5/1/2024HC WainwrightReiterated RatingBuy ➝ Buy$11.00
3/7/2024Lake Street CapitalInitiated CoverageBuy$12.00
3/1/2024MizuhoBoost Price TargetBuy ➝ Buy$13.00 ➝ $14.00
10/31/2023MizuhoLower Price TargetBuy ➝ Buy$14.00 ➝ $12.00
10/27/2023Craig HallumInitiated CoverageBuy$12.00
8/9/2023MizuhoBoost Price Target$12.00 ➝ $14.00
8/2/2023MizuhoBoost Price TargetBuy ➝ Buy$10.00 ➝ $12.00
 

Shocking prediction from firm that predicted President Kamala (Ad)

Prepare for President Kamala I won't be voting for her. Even so, I'm worried VP Kamala Harris could pull off a victory and become our next president. And it would be much worse than anything you might expect—especially when it comes to your money. Because likely WON'T get a second chance at recovering the money you stand to lose if she takes power.

Find out how to prepare.